Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 415289, 18 pages
http://dx.doi.org/10.1155/2015/415289
Review Article

Bone Regeneration from PLGA Micro-Nanoparticles

1Department of Oral Surgery and Implant Dentistry, University of Granada, 18011 Granada, Spain
2Department of Pathology, School of Medicine and IBIMER, University of Granada, 18012 Granada, Spain
3Biocolloid and Fluid Physics Group, Department of Applied Physics, University of Granada, 18071 Granada, Spain
4Department of Applied Physics II, University of Málaga, 29071 Málaga, Spain

Received 27 March 2015; Accepted 4 June 2015

Academic Editor: Hojae Bae

Copyright © 2015 Inmaculada Ortega-Oller et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Padial-Molina, P. Galindo-Moreno, and G. Avila-Ortiz, “Biomimetic ceramics in implant dentistry,” Minerva Biotecnologica, vol. 21, no. 3, pp. 173–186, 2009. View at Google Scholar · View at Scopus
  2. B. Al-Nawas and E. Schiegnitz, “Augmentation procedures using bone substitute materials or autogenous bone—a systematic review and meta-analysis,” European Journal of Oral Implantology, vol. 7, supplement 2, pp. S219–S234, 2014. View at Google Scholar · View at Scopus
  3. A. Katranji, P. Fotek, and H.-L. Wang, “Sinus augmentation complications: etiology and treatment,” Implant Dentistry, vol. 17, no. 3, pp. 339–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C. E. Misch, “Maxillary sinus augmentation for endosteal implants: organized alternative treatment plans,” The International Journal of Oral Implantology: Implantologist, vol. 4, no. 2, pp. 49–58, 1987. View at Google Scholar · View at Scopus
  5. C. Myeroff and M. Archdeacon, “Autogenous bone graft: donor sites and techniques,” The Journal of Bone & Joint Surgery—American Volume, vol. 93, no. 23, pp. 2227–2236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Avila, R. Neiva, C. E. Misch et al., “Clinical and histologic outcomes after the use of a novel allograft for maxillary sinus augmentation: a case series,” Implant Dentistry, vol. 19, no. 4, pp. 330–341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Froum, S. S. Wallace, N. Elian, S. C. Cho, and D. P. Tarnow, “Comparison of mineralized cancellous bone allograft (Puros) and anorganic bovine bone matrix (Bio-Oss) for sinus augmentation: histomorphometry at 26 to 32 weeks after grafting,” The International Journal of Periodontics & Restorative Dentistry, vol. 26, no. 6, pp. 543–551, 2006. View at Google Scholar · View at Scopus
  8. P. Galindo-Moreno, G. Ávila, J. E. Fernández-Barbero et al., “Evaluation of sinus floor elevation using a composite bone graft mixture,” Clinical Oral Implants Research, vol. 18, no. 3, pp. 376–382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Galindo-Moreno, I. Moreno-Riestra, G. Avila et al., “Effect of anorganic bovine bone to autogenous cortical bone ratio upon bone remodeling patterns following maxillary sinus augmentation,” Clinical Oral Implants Research, vol. 22, no. 8, pp. 857–864, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. L. Wheeler, “Sinus augmentation for dental implants: the use of alloplastic materials,” Journal of Oral and Maxillofacial Surgery, vol. 55, no. 11, pp. 1287–1293, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. S. S. Wallace and S. J. Froum, “Effect of maxillary sinus augmentation on the survival of endosseous dental implants. A systematic review.,” Annals of Periodontology/the American Academy of Periodontology, vol. 8, no. 1, pp. 328–343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Padial-Molina and H. F. Rios, “Stem cells, scaffolds and gene therapy for periodontal engineering,” Current Oral Health Reports, vol. 1, no. 1, pp. 16–25, 2014. View at Publisher · View at Google Scholar
  13. M. Padial-Molina, S. L. Volk, and H. F. Rios, “Periostin increases migration and proliferation of human periodontal ligament fibroblasts challenged by tumor necrosis factor -alpha and Porphyromonas gingivalis lipopolysaccharides,” Journal of Periodontal Research, vol. 49, no. 3, pp. 405–414, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Behnia, A. Khojasteh, M. Soleimani, A. Tehranchi, and A. Atashi, “Repair of alveolar cleft defect with mesenchymal stem cells and platelet derived growth factors: a preliminary report,” Journal of Cranio-Maxillofacial Surgery, vol. 40, no. 1, pp. 2–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Padial-Molina, J. T. Marchesan, A. D. Taut, Q. Jin, W. V. Giannobile, and H. F. Rios, “Methods to validate tooth-supporting regenerative therapies,” Methods in Molecular Biology, vol. 887, pp. 135–148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. R. Urist, “Bone: formation by autoinduction,” Science, vol. 150, no. 3698, pp. 893–899, 1965. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Boyne and S. D. Jones, “Demonstration of the osseoinductive effect of bone morphogenetic protein within endosseous dental implants,” Implant Dentistry, vol. 13, no. 2, pp. 180–184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. E. A. Wang, V. Rosen, J. S. D'Alessandro et al., “Recombinant human bone morphogenetic protein induces bone formation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 6, pp. 2220–2224, 1990. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Wozney, “The bone morphogenetic protein family and osteogenesis,” Molecular Reproduction and Development, vol. 32, no. 2, pp. 160–167, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Barboza, A. Caúla, and F. Machado, “Potential of recombinant human bone morphogenetic protein-2 in bone regeneration,” Implant Dentistry, vol. 8, no. 4, pp. 360–367, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. A. C. Carreira, G. G. Alves, W. F. Zambuzzi, M. C. Sogayar, and J. M. Granjeiro, “Bone morphogenetic proteins: structure, biological function and therapeutic applications,” Archives of Biochemistry and Biophysics, vol. 561, pp. 64–73, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. J. C. Bustos-Valenzuela, A. Fujita, E. Halcsik, J. M. Granjeiro, and M. C. Sogayar, “Unveiling novel genes upregulated by both rhBMP2 and rhBMP7 during early osteoblastic transdifferentiation of C2C12 cells,” BMC Research Notes, vol. 4, article 370, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Tsuji, A. Bandyopadhyay, B. D. Harfe et al., “BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing,” Nature Genetics, vol. 38, no. 12, pp. 1424–1429, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Tsuji, K. Cox, A. Bandyopadhyay, B. D. Harfe, C. J. Tabin, and V. Rosen, “BMP4 is dispensable for skeletogenesis and fracture-healing in the limb,” The Journal of Bone and Joint Surgery—American Volume, vol. 90, supplement 1, pp. 14–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Tsuji, K. Cox, L. Gamer, D. Graf, A. Economides, and V. Rosen, “Conditional deletion of BMP7 from the limb skeleton does not affect bone formation or fracture repair,” Journal of Orthopaedic Research, vol. 28, no. 3, pp. 384–389, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Chen, C. Deng, and Y.-P. Li, “TGF-beta and BMP signaling in osteoblast differentiation and bone formation,” International Journal of Biological Sciences, vol. 8, no. 2, pp. 272–288, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M.-C. Ramel and C. S. Hill, “Spatial regulation of BMP activity,” FEBS Letters, vol. 586, no. 14, pp. 1929–1941, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. A. C. Carreira, F. H. Lojudice, E. Halcsik, R. D. Navarro, M. C. Sogayar, and J. M. Granjeiro, “Bone morphogenetic proteins: facts, challenges, and future perspectives,” Journal of Dental Research, vol. 93, no. 4, pp. 335–345, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Deschaseaux, L. Sensébé, and D. Heymann, “Mechanisms of bone repair and regeneration,” Trends in Molecular Medicine, vol. 15, no. 9, pp. 417–429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. T. D. Mueller and J. Nickel, “Promiscuity and specificity in BMP receptor activation,” FEBS Letters, vol. 586, no. 14, pp. 1846–1859, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Sieber, J. Kopf, C. Hiepen, and P. Knaus, “Recent advances in BMP receptor signaling,” Cytokine & Growth Factor Reviews, vol. 20, no. 5-6, pp. 343–355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Sapkota, C. Alarcón, F. M. Spagnoli, A. H. Brivanlou, and J. Massagué, “Balancing BMP signaling through integrated inputs into the Smad1 linker,” Molecular Cell, vol. 25, no. 3, pp. 441–454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. W. F. McKay, S. M. Peckham, and J. M. Badura, “A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft),” International Orthopaedics, vol. 31, no. 6, pp. 729–734, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Hong, D. Boyd, S. D. Beyea, and M. Bezuhly, “Enhancement of bone consolidation in mandibular distraction osteogenesis: a contemporary review of experimental studies involving adjuvant therapies,” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 66, no. 7, pp. 883–895, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. D. B. Spagnoli and R. E. Marx, “Dental implants and the use of rhBMP-2,” Dental Clinics of North America, vol. 55, no. 4, pp. 883–907, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Nevins, C. Kirker-Head, M. Nevins, J. A. Wozney, R. Palmer, and D. Graham, “Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2,” The International Journal of Periodontics & Restorative Dentistry, vol. 16, no. 1, pp. 8–19, 1996. View at Google Scholar · View at Scopus
  37. P. J. Boyne, L. C. Lilly, R. E. Marx et al., “De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation,” Journal of Oral and Maxillofacial Surgery, vol. 63, no. 12, pp. 1693–1707, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Torrecillas-Martinez, A. Monje, M. A. Pikos et al., “Effect of rhBMP-2 upon maxillary sinus augmentation: a comprehensive review,” Implant Dentistry, vol. 22, no. 3, pp. 232–237, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Lee, C. Susin, N. A. Rodriguez et al., “Sinus augmentation using rhBMP-2/ACS in a mini-pig model: relative efficacy of autogenous fresh particulate iliac bone grafts,” Clinical Oral Implants Research, vol. 24, no. 5, pp. 497–504, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. R. G. Triplett, M. Nevins, R. E. Marx et al., “Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 9, pp. 1947–1960, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. D. W. K. Kao, A. Kubota, M. Nevins, and J. P. Fiorellini, “The negative effect of combining rhBMP-2 and Bio-Oss on bone formation for maxillary sinus augmentation,” The International Journal of Periodontics & Restorative Dentistry, vol. 32, no. 1, pp. 61–67, 2012. View at Google Scholar · View at Scopus
  42. O. Hanisch, D. N. Tatakis, M. D. Rohrer, P. S. Wöhrle, J. M. Wozney, and U. M. E. Wikesjö, “Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates,” The International Journal of Oral & Maxillofacial Implants, vol. 12, no. 6, pp. 785–792, 1997. View at Google Scholar · View at Scopus
  43. K. Wada, A. Niimi, K. Watanabe, T. Sawai, and M. Ueda, “Maxillary sinus floor augmentation in rabbits: a comparative histologic-histomorphometric study between rhBMP-2 and autogenous bone,” The International Journal of Periodontics & Restorative Dentistry, vol. 21, no. 3, pp. 253–263, 2001. View at Google Scholar · View at Scopus
  44. R. Fu, S. Selph, M. McDonagh et al., “Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis,” Annals of Internal Medicine, vol. 158, no. 12, pp. 890–902, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Tian, Y. Zhu, J. Qiu et al., “Synthesis and characterization of UPPE-PLGA-rhBMP2 scaffolds for bone regeneration,” Journal of Huazhong University of Science and Technology—Medical Science, vol. 32, no. 4, pp. 563–570, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Rodríguez-Évora, E. García-Pizarro, C. del Rosario et al., “Smurf1 knocked-down, mesenchymal stem cells and BMP-2 in an electrospun system for bone regeneration,” Biomacromolecules, vol. 15, no. 4, pp. 1311–1322, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Reyes, A. Delgado, R. Solis et al., “Cartilage repair by local delivery of TGF-β1 or BMP-2 from a novel, segmented polyurethane/polylactic-co-glycolic bilayered scaffold,” Journal of Biomedical Materials Research Part A, 2013. View at Publisher · View at Google Scholar
  48. C. V. Rahman, D. Ben-David, A. Dhillon et al., “Controlled release of BMP-2 from a sintered polymer scaffold enhances bone repair in a mouse calvarial defect model,” Journal of Tissue Engineering and Regenerative Medicine, vol. 8, no. 1, pp. 59–66, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Lupu-Haber, O. Pinkas, S. Boehm, T. Scheper, C. Kasper, and M. Machluf, “Functionalized PLGA-doped zirconium oxide ceramics for bone tissue regeneration,” Biomedical Microdevices, vol. 15, no. 6, pp. 1055–1066, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. J. D. Wink, P. A. Gerety, R. D. Sherif et al., “Sustained delivery of rhBMP-2 by means of poly(lactic-co-glycolic acid) microspheres: cranial bone regeneration without heterotopic ossification or craniosynostosis,” Plastic and Reconstructive Surgery, vol. 134, no. 1, pp. 51–59, 2014. View at Google Scholar · View at Scopus
  51. W.-G. La, S.-W. Kang, H. S. Yang et al., “The efficacy of bone morphogenetic protein-2 depends on its mode of delivery,” Artificial Organs, vol. 34, no. 12, pp. 1150–1153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. Y.-I. Chung, K.-M. Ahn, S.-H. Jeon, S.-Y. Lee, J.-H. Lee, and G. Tae, “Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex,” Journal of Controlled Release, vol. 121, no. 1-2, pp. 91–99, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. O. Jeon, S. J. Song, H. S. Yang et al., “Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery,” Biochemical and Biophysical Research Communications, vol. 369, no. 2, pp. 774–780, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Yilgor, K. Tuzlakoglu, R. L. Reis, N. Hasirci, and V. Hasirci, “Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering,” Biomaterials, vol. 30, no. 21, pp. 3551–3559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Rodríguez-Évora, A. Delgado, R. Reyes et al., “Osteogenic effect of local, long versus short term BMP-2 delivery from a novel SPU-PLGA-βTCP concentric system in a critical size defect in rats,” European Journal of Pharmaceutical Sciences, vol. 49, no. 5, pp. 873–884, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. I. d'Angelo, M. Garcia-Fuentes, Y. Parajó et al., “Nanoparticles based on PLGA: poloxamer blends for the delivery of proangiogenic growth factors,” Molecular Pharmaceutics, vol. 7, no. 5, pp. 1724–1733, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. J. A. Schrier, B. F. Fink, J. B. Rodgers, H. C. Vasconez, and P. P. DeLuca, “Effect of a freeze-dried CMC/PLGA microsphere matrix of rhBMP-2 on bone healing,” AAPS PharmSciTech, vol. 2, no. 3, article E18, 2001. View at Google Scholar · View at Scopus
  58. A. Lochmann, H. Nitzsche, S. von Einem, E. Schwarz, and K. Mäder, “The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres,” Journal of Controlled Release, vol. 147, no. 1, pp. 92–100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. L. J. White, G. T. S. Kirby, H. C. Cox et al., “Accelerating protein release from microparticles for regenerative medicine applications,” Materials Science and Engineering C: Materials for Biological Applications, vol. 33, no. 5, pp. 2578–2583, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Pirooznia, S. Hasannia, A. S. Lotfi, and M. Ghanei, “Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases,” Journal of Nanobiotechnology, vol. 10, article 20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Ronga, A. Fagetti, G. Canton, E. Paiusco, M. F. Surace, and P. Cherubino, “Clinical applications of growth factors in bone injuries: experience with BMPs,” Injury, vol. 44, supplement 1, pp. S34–S39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. J. G. Devine, J. R. Dettori, J. C. France, E. Brodt, and R. A. McGuire, “The use of rhBMP in spine surgery: is there a cancer risk?” Evidence-Based Spine-Care Journal, vol. 3, no. 2, pp. 35–41, 2012. View at Publisher · View at Google Scholar
  63. E. J. Carragee, E. L. Hurwitz, and B. K. Weiner, “A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned,” The Spine Journal, vol. 11, no. 6, pp. 471–491, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. M. C. Simmonds, J. V. E. Brown, M. K. Heirs et al., “Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data,” Annals of Internal Medicine, vol. 158, no. 12, pp. 877–889, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. V. H.-Y. Chung, A. Y.-L. Chen, L.-B. Jeng, C.-C. Kwan, S.-H. Cheng, and S. C.-N. Chang, “Engineered autologous bone marrow mesenchymal stem cells: alternative to cleft alveolar bone graft surgery,” Journal of Craniofacial Surgery, vol. 23, no. 5, pp. 1558–1563, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. T. A. Ratko, S. E. Belinson, D. J. Samson, C. Bonnell, K. M. Ziegler, and N. Aronson, Bone Morphogenetic Protein: The State of the Evidence of On-Label and Off-Label Use, Agency for Healthcare Research and Quality, Rockville, Md, USA, 2010.
  67. G. Barratt, “Colloidal drug carriers: achievements and perspectives,” Cellular and Molecular Life Sciences, vol. 60, no. 1, pp. 21–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. V. W. Bramwell and Y. Perrie, “Particulate delivery systems for vaccines,” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 22, no. 2, pp. 151–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. N. Csaba, M. Garcia-Fuentes, and M. J. Alonso, “The performance of nanocarriers for transmucosal drug delivery,” Expert Opinion on Drug Delivery, vol. 3, no. 4, pp. 463–478, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. M. J. Santander-Ortega, T. Stauner, B. Loretz et al., “Nanoparticles made from novel starch derivatives for transdermal drug delivery,” Journal of Controlled Release, vol. 141, no. 1, pp. 85–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. W. Jiang, R. K. Gupta, M. C. Deshpande, and S. P. Schwendeman, “Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens,” Advanced Drug Delivery Reviews, vol. 57, no. 3, pp. 391–410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. T. R. Shantha Kumar, K. Soppimath, and S. K. Nachaegari, “Novel delivery technologies for protein and peptide therapeutics,” Current Pharmaceutical Biotechnology, vol. 7, no. 4, pp. 261–276, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. F. Danhier, E. Ansorena, J. M. Silva, R. Coco, A. Le Breton, and V. Préat, “PLGA-based nanoparticles: an overview of biomedical applications,” Journal of Controlled Release, vol. 161, no. 2, pp. 505–522, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Kumari, S. K. Yadav, and S. C. Yadav, “Biodegradable polymeric nanoparticles based drug delivery systems,” Colloids and Surfaces B: Biointerfaces, vol. 75, no. 1, pp. 1–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. H. K. Makadia and S. J. Siegel, “Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier,” Polymers, vol. 3, no. 3, pp. 1377–1397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Mohamed and C. F. van der Walle, “Engineering biodegradable polyester particles with specific drug targeting and drug release properties,” Journal of Pharmaceutical Sciences, vol. 97, no. 1, pp. 71–87, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. G. A. Silva, O. P. Coutinho, P. Ducheyne, and R. L. Reis, “Materials in particulate form for tissue engineering. 2. Applications in bone,” Journal of Tissue Engineering and Regenerative Medicine, vol. 1, no. 2, pp. 97–109, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Zhang and H. Uludag, “Nanoparticulate systems for growth factor delivery,” Pharmaceutical Research, vol. 26, no. 7, pp. 1561–1580, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. V. E. Santo, M. E. Gomes, J. F. Mano, and R. L. Reis, “From nano-to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering,” Nanomedicine, vol. 7, no. 7, pp. 1045–1066, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. M.-K. Tran, A. Swed, and F. Boury, “Preparation of polymeric particles in CO2 medium using non-toxic solvents: formulation and comparisons with a phase separation method,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 82, no. 3, pp. 498–507, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. B. Ertl, F. Heigl, M. Wirth, and F. Gabor, “Lectin-mediated bioadhesion: preparation, stability and Caco-2 binding of wheat germ agglutinin-functionalized poly-(D,L-lactic-co-glycolic acid)-microspheres,” Journal of Drug Targeting, vol. 8, no. 3, pp. 173–184, 2000. View at Publisher · View at Google Scholar · View at Scopus
  82. M. L. Hans and A. M. Lowman, “Biodegradable nanoparticles for drug delivery and targeting,” Current Opinion in Solid State and Materials Science, vol. 6, no. 4, pp. 319–327, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. D. Blanco and M. J. Alonso, “Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 45, no. 3, pp. 285–294, 1998. View at Publisher · View at Google Scholar · View at Scopus
  84. N. Csaba, P. Caamaño, A. Sánchez, F. Domínguez, and M. J. Alonso, “PLGA: poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery,” Biomacromolecules, vol. 6, no. 1, pp. 271–278, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. C. Sturesson and J. Carlfors, “Incorporation of protein in PLG-microspheres with retention of bioactivity,” Journal of Controlled Release, vol. 67, no. 2-3, pp. 171–178, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. I. D. Rosca, F. Watari, and M. Uo, “Microparticle formation and its mechanism in single and double emulsion solvent evaporation,” Journal of Controlled Release, vol. 99, no. 2, pp. 271–280, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. F. T. Meng, G. H. Ma, W. Qiu, and Z. G. Su, “W/O/W double emulsion technique using ethyl acetate as organic solvent: effects of its diffusion rate on the characteristics of microparticles,” Journal of Controlled Release, vol. 91, no. 3, pp. 407–416, 2003. View at Publisher · View at Google Scholar · View at Scopus
  88. R. Ghaderi and J. Carlfors, “Biological activity of lysozyme after entrapment in poly (d,l-lactide-co-glycolide)-microspheres,” Pharmaceutical Research, vol. 14, no. 11, pp. 1556–1562, 1997. View at Publisher · View at Google Scholar · View at Scopus
  89. H. Wang, S. C. G. Leeuwenburgh, Y. Li, and J. A. Jansen, “The use of micro- and nanospheres as functional components for bone tissue regeneration,” Tissue Engineering Part B: Reviews, vol. 18, no. 1, pp. 24–39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Xiong, X. Zhao, B. C. Heng, K. W. Ng, and J. S.-C. Loo, “Cellular uptake of Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles synthesized through solvent emulsion evaporation and nanoprecipitation method,” Biotechnology Journal, vol. 6, no. 5, pp. 501–508, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. L. Y. T. Chou, K. Ming, and W. C. W. Chan, “Strategies for the intracellular delivery of nanoparticles,” Chemical Society Reviews, vol. 40, no. 1, pp. 233–245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. M. J. Santander-Ortega, M. V. Lozano-López, D. Bastos-González, J. M. Peula-García, and J. L. Ortega-Vinuesa, “Novel core-shell lipid-chitosan and lipid-poloxamer nanocapsules: stability by hydration forces,” Colloid and Polymer Science, vol. 288, no. 2, pp. 159–172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. Y.-Y. Yang, T.-S. Chung, and N. Ping Ng, “Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method,” Biomaterials, vol. 22, no. 3, pp. 231–241, 2001. View at Publisher · View at Google Scholar · View at Scopus
  94. T. Feczkó, J. Tóth, and J. Gyenis, “Comparison of the preparation of PLGA-BSA nano- and microparticles by PVA, poloxamer and PVP,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 319, no. 1–3, pp. 188–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. M. J. Santander-Ortega, D. Bastos-González, and J. L. Ortega-Vinuesa, “Electrophoretic mobility and colloidal stability of PLGA particles coated with IgG,” Colloids and Surfaces B: Biointerfaces, vol. 60, no. 1, pp. 80–88, 2007. View at Publisher · View at Google Scholar · View at Scopus
  96. Y.-Y. Yang, H.-H. Chia, and T.-S. Chung, “Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method,” Journal of Controlled Release, vol. 69, no. 1, pp. 81–96, 2000. View at Publisher · View at Google Scholar · View at Scopus
  97. D.-L. Fang, Y. Chen, B. Xu et al., “Development of lipid-shell and polymer core nanoparticles with water-soluble salidroside for anti-cancer therapy,” International Journal of Molecular Sciences, vol. 15, no. 3, pp. 3373–3388, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. G. Ratzinger, U. Länger, L. Neutsch, F. Pittner, M. Wirth, and F. Gabor, “Surface modification of PLGA particles: the interplay between stabilizer, ligand size, and hydrophobic interactions,” Langmuir, vol. 26, no. 3, pp. 1855–1859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. S.-S. Feng and G. Huang, “Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers,” Journal of Controlled Release, vol. 71, no. 1, pp. 53–69, 2001. View at Publisher · View at Google Scholar · View at Scopus
  100. J. M. Chan, L. Zhang, K. P. Yuet et al., “PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery,” Biomaterials, vol. 30, no. 8, pp. 1627–1634, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Fraylich, W. Wang, K. Shakesheff, C. Alexander, and B. Saunders, “Poly(D,L-lactide-co-glycolide) dispersions containing pluronics: from particle preparation to temperature-triggered aggregation,” Langmuir, vol. 24, no. 15, pp. 7761–7768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. M. J. Santander-Ortega, J. M. Peula-García, F. M. Goycoolea, and J. L. Ortega-Vinuesa, “Chitosan nanocapsules: effect of chitosan molecular weight and acetylation degree on electrokinetic behaviour and colloidal stability,” Colloids and Surfaces B: Biointerfaces, vol. 82, no. 2, pp. 571–580, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. J. S. Tan, D. E. Butterfield, C. L. Voycheck, K. D. Caldwell, and J. T. Li, “Surface modification of nanoparticles by PEO/PPO block copolymers to minimize interactions with blood components and prolong blood circulation in rats,” Biomaterials, vol. 14, no. 11, pp. 823–833, 1993. View at Publisher · View at Google Scholar · View at Scopus
  104. C. Bouissou, U. Potter, H. Altroff, H. Mardon, and C. van der Walle, “Controlled release of the fibronectin central cell binding domain from polymeric microspheres,” Journal of Controlled Release, vol. 95, no. 3, pp. 557–566, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. R. Gref, Y. Minamitake, M. T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer, “Biodegradable long-circulating polymeric nanospheres,” Science, vol. 263, no. 5153, pp. 1600–1603, 1994. View at Publisher · View at Google Scholar · View at Scopus
  106. P. Paolicelli, C. Prego, A. Sanchez, and M. J. Alonso, “Surface-modified PLGA-based nanoparticles that can efficiently associate and deliver virus-like particles,” Nanomedicine, vol. 5, no. 6, pp. 843–853, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. I. Brigger, C. Dubernet, and P. Couvreur, “Nanoparticles in cancer therapy and diagnosis,” Advanced Drug Delivery Reviews, vol. 54, no. 5, pp. 631–651, 2002. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Giteau, M. C. Venier-Julienne, A. Aubert-Pouëssel, and J. P. Benoit, “How to achieve sustained and complete protein release from PLGA-based microparticles?” International Journal of Pharmaceutics, vol. 350, no. 1-2, pp. 14–26, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. E. R. Balmayor, G. A. Feichtinger, H. S. Azevedo, M. van Griensven, and R. L. Reis, “Starch-poly-ε-caprolactone microparticles reduce the needed amount of BMP-2,” Clinical Orthopaedics and Related Research, vol. 467, no. 12, pp. 3138–3148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. M. J. Santander-Ortega, D. Bastos-González, J. L. Ortega-Vinuesa, and M. J. Alonso, “Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization,” Journal of Biomedical Nanotechnology, vol. 5, no. 1, pp. 45–53, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. L. Meinel, O. E. Illi, J. Zapf, M. Malfanti, H. Peter Merkle, and B. Gander, “Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres,” Journal of Controlled Release, vol. 70, no. 1-2, pp. 193–202, 2001. View at Publisher · View at Google Scholar · View at Scopus
  112. C. Srinivasan, Y. K. Katare, T. Muthukumaran, and A. K. Panda, “Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles,” Journal of Microencapsulation, vol. 22, no. 2, pp. 127–138, 2005. View at Publisher · View at Google Scholar · View at Scopus
  113. M. Tobío, S. P. Schwendeman, Y. Guo, J. McIver, R. Langer, and M. J. Alonso, “Improved immunogenicity of a core-coated tetanus toxoid delivery system,” Vaccine, vol. 18, no. 7-8, pp. 618–622, 1999. View at Publisher · View at Google Scholar · View at Scopus
  114. D. K. Malik, S. Baboota, A. Ahuja, S. Hasan, and J. Ali, “Recent advances in protein and peptide drug delivery systems,” Current Drug Delivery, vol. 4, no. 2, pp. 141–151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. J. L. Cleland, “Protein delivery from biodegradable microspheres,” in Protein Delivery: Physical Systems, L. M. Sanders and R. W. Hendron, Eds., pp. 1–41, Plenum Press, New York, NY, USA, 1997. View at Google Scholar
  116. S. H. Oh, T. H. Kim, and J. H. Lee, “Creating growth factor gradients in three dimensional porous matrix by centrifugation and surface immobilization,” Biomaterials, vol. 32, no. 32, pp. 8254–8260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  117. B. N. Brown, J. E. Valentin, A. M. Stewart-Akers, G. P. McCabe, and S. F. Badylak, “Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component,” Biomaterials, vol. 30, no. 8, pp. 1482–1491, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. B. N. Brown, J. M. Freund, L. Han et al., “Comparison of three methods for the derivation of a biologic scaffold composed of adipose tissue extracellular matrix,” Tissue Engineering—Part C: Methods, vol. 17, no. 4, pp. 411–421, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. B. Li, T. Yoshii, A. E. Hafeman, J. S. Nyman, J. C. Wenke, and S. A. Guelcher, “The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora,” Biomaterials, vol. 30, no. 35, pp. 6768–6779, 2009. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Paillard-Giteau, V. T. Tran, O. Thomas et al., “Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 75, no. 2, pp. 128–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  121. B. P. Nair and C. P. Sharma, “Poly(lactide-co-glycolide)-laponite-F68 nanocomposite vesicles through a single-step double-emulsion method for the controlled release of doxorubicin,” Langmuir, vol. 28, no. 9, pp. 4559–4564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  122. P. Yilgor, N. Hasirci, and V. Hasirci, “Sequential BMP-2/BMP-7 delivery from polyester nanocapsules,” Journal of Biomedical Materials Research—Part A, vol. 93, no. 2, pp. 528–536, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. Y. Xia, Q. Xu, C.-H. Wang, and D. W. Pack, “Protein encapsulation in and release from monodisperse double-wall polymer microspheres,” Journal of Pharmaceutical Sciences, vol. 102, no. 5, pp. 1601–1609, 2013. View at Publisher · View at Google Scholar · View at Scopus
  124. Y. Fu, L. Du, Q. Wang et al., “In vitro sustained release of recombinant human bone morphogenetic protein-2 microspheres embedded in thermosensitive hydrogels,” Die Pharmazie, vol. 67, no. 4, pp. 299–303, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. D. H. R. Kempen, L. Lu, T. E. Hefferan et al., “Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering,” Biomaterials, vol. 29, no. 22, pp. 3245–3252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  126. D. H. R. Kempen, L. Lu, A. Heijink et al., “Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration,” Biomaterials, vol. 30, no. 14, pp. 2816–2825, 2009. View at Publisher · View at Google Scholar · View at Scopus
  127. H. Nie, M.-L. Ho, C.-K. Wang, C.-H. Wang, and Y.-C. Fu, “BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice,” Biomaterials, vol. 30, no. 5, pp. 892–901, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. F. Wegman, Y. van der Helm, F. C. Öner, W. J. A. Dhert, and J. Alblas, “Bone morphogenetic protein-2 plasmid DNA as a substitute for bone morphogenetic protein-2 protein in bone tissue engineering,” Tissue Engineering Part A, vol. 19, no. 23-24, pp. 2686–2692, 2013. View at Publisher · View at Google Scholar · View at Scopus
  129. J. Fischer, A. Kolk, S. Wolfart et al., “Future of local bone regeneration—protein versus gene therapy,” Journal of Cranio-Maxillofacial Surgery, vol. 39, no. 1, pp. 54–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  130. C. Qiao, K. Zhang, H. Jin et al., “Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo,” International Journal of Nanomedicine, vol. 8, pp. 2985–2995, 2013. View at Publisher · View at Google Scholar · View at Scopus
  131. C. H. Evans, “Gene delivery to bone,” Advanced Drug Delivery Reviews, vol. 64, no. 12, pp. 1331–1340, 2012. View at Publisher · View at Google Scholar · View at Scopus
  132. C.-H. Lu, Y.-H. Chang, S.-Y. Lin, K.-C. Li, and Y.-C. Hu, “Recent progresses in gene delivery-based bone tissue engineering,” Biotechnology Advances, vol. 31, no. 8, pp. 1695–1706, 2013. View at Publisher · View at Google Scholar · View at Scopus
  133. T. N. Vo, F. K. Kasper, and A. G. Mikos, “Strategies for controlled delivery of growth factors and cells for bone regeneration,” Advanced Drug Delivery Reviews, vol. 64, no. 12, pp. 1292–1309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  134. W. Ji, H. Wang, J. J. J. P. van den Beucken et al., “Local delivery of small and large biomolecules in craniomaxillofacial bone,” Advanced Drug Delivery Reviews, vol. 64, no. 12, pp. 1152–1164, 2012. View at Publisher · View at Google Scholar · View at Scopus
  135. V. Luginbuehl, L. Meinel, H. P. Merkle, and B. Gander, “Localized delivery of growth factors for bone repair,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 58, no. 2, pp. 197–208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  136. P. Kocbek, N. Obermajer, M. Cegnar, J. Kos, and J. Kristl, “Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody,” Journal of Controlled Release, vol. 120, no. 1-2, pp. 18–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  137. J. Cheng, B. A. Teply, I. Sherifi et al., “Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery,” Biomaterials, vol. 28, no. 5, pp. 869–876, 2007. View at Publisher · View at Google Scholar · View at Scopus
  138. C. Romagnoli, F. D'Asta, and M. L. Brandi, “Drug delivery using composite scaffolds in the context of bone tissue engineering,” Clinical Cases in Mineral and Bone Metabolism, vol. 10, no. 3, pp. 155–161, 2013. View at Google Scholar · View at Scopus
  139. D. Puppi, X. Zhang, L. Yang, F. Chiellini, X. Sun, and E. Chiellini, “Nano/microfibrous polymeric constructs loaded with bioactive agents and designed for tissue engineering applications: a review,” Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 102, no. 7, pp. 1562–1579, 2014. View at Publisher · View at Google Scholar · View at Scopus